(Q45895946)

17 December 2017

title

IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma (English)

1 reference

17 December 2017

esophageal squamous cell carcinoma

main subject

1 reference

Asuka Murata

1

1 reference

17 December 2017

Yoshifumi Baba

2

1 reference

17 December 2017

Masayuki Watanabe

3

1 reference

17 December 2017

Hironobu Shigaki

4

1 reference

17 December 2017

Keisuke Miyake

5

1 reference

17 December 2017

Takatsugu Ishimoto

6

1 reference

17 December 2017

Masaaki Iwatsuki

7

1 reference

17 December 2017

Shiro Iwagami

8

1 reference

17 December 2017

Naoya Yoshida

9

1 reference

17 December 2017

Eiji Oki

10

1 reference

17 December 2017

Masaru Morita

11

1 reference

17 December 2017

Mitsuyoshi Nakao

12

1 reference

17 December 2017

Hideo Baba

13

1 reference

17 December 2017

publication date

7 December 2013

1 reference

17 December 2017

Annals of Surgical Oncology

published in

1 reference

17 December 2017

volume

21

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

page(s)

1166-1174

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1245/s10434-013-3414-7

exact match

0 references

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Comprehensive molecular characterization of human colon and rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Gli2 and p53 cooperate to regulate IGFBP-3- mediated chondrocyte apoptosis in the progression from benign to malignant cartilage tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Relaxation of imprinted genes in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Somatic overgrowth associated with overexpression of insulin-like growth factor II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

A new link between epigenetic progenitor lesions in cancer and the dynamics of signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Soluble IGF2 receptor rescues Apc(Min/+) intestinal adenoma progression induced by Igf2 loss of imprinting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Reporting recommendations for tumor marker prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Immunohistochemical evaluation of p53, FHIT, and IGF2 gene expression in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of lymph node metastasis and gastric corpus cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

A systematic approach to therapeutic target selection in oesophago-gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Open questions in oesophageal adenocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Cancer epigenetics reaches mainstream oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

The history of cancer epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

In epigenetic therapy, less is more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Epigenetic therapy of cancer: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3414-7

10.1245/S10434-013-3414-7

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

1034284172

0 references

1 reference

17 December 2017